Log In
Print this Print this

CriPec doxorubicine (CD103)

  Manage Alerts
Collapse Summary General Information
Company Cristal Therapeutics
DescriptionNanoparticle formulation of doxorubicine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today